학술논문

P2.04-92 Neoadjuvant Durvalumab With or Without Sub-Ablative Stereotactic Radiotherapy (SBRT) in Patients with Resectable NSCLC (NCT02904954)
Document Type
Abstract
Source
In Journal of Thoracic Oncology October 2019 14(10) Supplement:S746-S746
Subject
Language
ISSN
1556-0864